Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMA business hours over holiday period 20 Δεκέμβριος 2022NewsCorporateCOVID-19 Facilitating Decentralised Clinical Trials in the EU 19 Δεκέμβριος 2022NewsHumanClinical trials EMA Management Board: highlights of December 2022 meeting 16 Δεκέμβριος 2022NewsCorporate Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 16 Δεκέμβριος 2022NewsHumanCOVID-19Medicines First gene therapy to treat haemophilia B 16 Δεκέμβριος 2022NewsHumanMedicines ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2 9 Δεκέμβριος 2022NewsHumanCOVID-19Medicines ECDC and EMA collaborate on vaccine safety and effectiveness monitoring studies 8 Δεκέμβριος 2022NewsHumanVaccines ETF concludes that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary vaccination 6 Δεκέμβριος 2022NewsHumanCOVID-19Medicines Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022 2 Δεκέμβριος 2022NewsHumanPharmacovigilanceReferrals EMA recommends withdrawal of pholcodine medicines from EU market 2 Δεκέμβριος 2022NewsHumanReferrals 1 … 36 37 38 39 40 Page 40 of 384 41 42 43 44 … 384
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 December 2022 16 Δεκέμβριος 2022NewsHumanCOVID-19Medicines
ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-2 9 Δεκέμβριος 2022NewsHumanCOVID-19Medicines
ECDC and EMA collaborate on vaccine safety and effectiveness monitoring studies 8 Δεκέμβριος 2022NewsHumanVaccines
ETF concludes that bivalent original/Omicron BA.4-5 mRNA vaccines may be used for primary vaccination 6 Δεκέμβριος 2022NewsHumanCOVID-19Medicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28 November - 1 December 2022 2 Δεκέμβριος 2022NewsHumanPharmacovigilanceReferrals